OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutical Sciences is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	207
In vitro identification of decreased function genetic variants of ABCB1	176
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	167
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	119
Editorial Board	117
3D printed extended-release hydrochlorothiazide tablets	116
Application of a forward design-based multi-attribute decision-making method in quality assessment in pharmaceutical tablet manufacturing	105
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	94
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	91
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	88
Esomeprazole prevents oxaliplatin-induced peripheral neuropathy through inhibiting organic cation transporter 2 in mice	66
Opportunities of topical drug products in a changing dermatological landscape	65
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia	63
Development and optimization of Soluplus®/Pluronic-based polymeric micelles for bicalutamide delivery: characterization, lyophilization, stability, and cellular studies	56
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation	53
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies	52
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	52
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	52
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue	50
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	50
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	49
Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols	48
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	48
Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism	46
Microparticles and multi-unit systems for advanced drug delivery	45

Nitrite testing in excipients – Industry best practices	45
Impact of protein adsorption during biopharmaceutical manufacture & storage	40
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation	39
The effect of formulation composition and flow conditions on the robustness of semisolid extrusion 3D printing: a case study on poorly water-soluble itraconazole for oral dosage form production	39
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	39
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	38
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach	38
Stability evaluation from hydrogen peroxide spiking studies	37
Virtual special issue of Nordic POP: Patient-oriented products	37
Towards optimization of dexamethasone therapy in the maintenance phase of pediatric acute lymphoblastic leukemia: A population pharmacokinetic and pharmacodynamic study of dexamethasone and metabolite	37
Controlled release and extended pulmonary retention of inhaled therapeutics: A review	36